|
KMID : 0438420100170010007
|
|
Korean Journal of Bone Metabolism
2010 Volume.17 No. 1 p.7 ~ p.12
|
|
|
Osteoporosis Reimbursement Policy: United States of America, Europe and Korea
|
|
Choi Hyung-Jin
Yoon Hyun-Koo
Shin Chan-Soo
|
|
|
Abstract
|
|
|
Osteoporosis and its related fractures have become a rapidly increasing health problem in Korea. Osteoporosis reimbursement policy is an essential part of public health effort to control this national threat. The osteoporosis reimbursement policies of United Stated of America, Europe and Korea are discussed. Medicare, the social insurance
program in United States of America, provides a national reimbursement program for bone mineral density measurements.
However, regarding the osteoporosis medicines in United States of America, the reimbursement policy will vary widely
according to the district of residence and the insurance plan of the patient. In Europe, most of countries have a national
reimbursement policy that covers bone mineral density measurements and medicines for osteoporosis. The criteria for
reimbursement of osteoporosis medicines are T-score ≤ -2.5 and/or other risk factors, in general. And in some European
countries, the criterion for T-score is ≤ -3.0. The reimbursement policy of bone mineral density measurements and
osteoporosis medicine in Korea is similar or slightly narrower compared to that of European countries. And the reimbursement criteria for osteoporosis medicine in Korea do not include other risk factors (beside T-score), in contrast
to that of European countries.
|
|
|
KEYWORD
|
|
|
Osteoporosis, Reimbursement, USA, Europe, Korea
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|